معرفی
Dr. Humphrey Fonge is a Full Professor at the Faculty of Pharmacy, Université Laval, specializing in radiopharmacy and cancer theranostics. His research focuses on developing radiolabeled agents for molecular imaging and targeted radiotherapy, with an emphasis on HER2 and EGFR-positive cancers.
- Education: PhD in Radiopharmacy (Katholieke Universiteit Leuven), MBA (University of Toronto)
- Training: Academic radiopharmacist (Saskatchewan Health Authority), postdoctoral work in theranostics (University of Toronto)
His program investigates pharmaceutical-grade radionuclides, preclinical evaluation of theranostic agents, and the impact of tumor environments on radiopharmaceutical efficacy. Recent studies involve Ac-225/67Cu-labeled antibodies for colorectal, breast, and neuroendocrine cancers.
Key collaborations include the Saskatchewan Health Authority and University of Toronto. Students in his lab include Jessica Pougoue Ketchemen (postdoc), Katrina Bato (graduate), and Emmanuel Nwangele (graduate).